BridgeMD
New treatment option for Hernia, Ventral
Official title Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias
ClinicalTrials.gov ID: NCT05734222
What this study is testing
- What it's testing
- The goal of our work of optimization of the treatment of postoperative hernias is to improve the results of treatment of patients with median and median-lateral postoperative hernias of medium (W2) and large (W3) sizes by developing new surgical techniques. The main questions it aims to answer are: 1.
- Time commitment: about 3 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 88
You may be able to join if
- The study will include patients with postoperative ventral hernias of median and lateral localization and an average hernial gate width from 4.1 to...
You likely can't join if
- Patients without postoperative ventral hernias median and lateral localization
The study team makes the final eligibility decision.
Where it's taking place
- Samara, Russia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 88 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Samara, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.